Skip to content

Drug interactions

Rosiglitazone + Somatrogon

Severity: Moderate

Rosiglitazone and Somatrogon: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Somatrogon, a long-acting growth hormone, can reduce insulin sensitivity and raise glucose levels. This may weaken the glycemic effect of rosiglitazone in patients with diabetes.

What this interaction means in plain words

Rosiglitazone and Somatrogon can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Rosiglitazone belongs to Endocrine; Somatrogon belongs to Endocrine.

Evidence level: Moderate

Why it happens

Pharmacodynamic antagonism: growth hormone induces insulin resistance, opposing the insulin-sensitizing action of rosiglitazone.

What to do

Monitor blood glucose and HbA1c when somatrogon is started or its dose is changed. Increase the rosiglitazone dose or add other antidiabetic treatment if control worsens.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Rosiglitazone and Somatrogon, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Rosiglitazone with Somatrogon?

MediHelp rates the interaction as moderate. Rosiglitazone and Somatrogon can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Somatrogon, a long-acting growth hormone, can reduce insulin sensitivity and raise glucose levels. This may weaken the glycemic effect of rosiglitazone in patients with diabetes.

How serious is the interaction between Rosiglitazone and Somatrogon?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose and HbA1c when somatrogon is started or its dose is changed. Increase the rosiglitazone dose or add other antidiabetic treatment if control worsens.

What other medicines interact with Rosiglitazone?

MediHelp also lists interactions of Rosiglitazone with, for example, Insulin aspart protamine / insulin aspart, Insulin aspart-insulin aspart protamine, Insulin aspart. The full list is on the Rosiglitazone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in